Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Mariana MáčajováInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-840 05 Bratislava, Slovakia.ORCID 0000-0002-4034-6001
Ľuboš AmbroCenter for Interdisciplinary Biosciences, Technology and Innovation Park, Pavol Jozef Šafárik University in Košice, Jesenná 5, SK-041 54 Košice, Slovakia.ORCID 0000-0003-4398-1665
Majlinda MetaInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-840 05 Bratislava, Slovakia.
Ľuboš ZauškaDepartment of Inorganic Chemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Moyzesova 11, SK-041 54 Košice, Slovakia.
Terézia GulyásováCenter for Interdisciplinary Biosciences, Technology and Innovation Park, Pavol Jozef Šafárik University in Košice, Jesenná 5, SK-041 54 Košice, Slovakia.
Boris BilčíkInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-840 05 Bratislava, Slovakia.ORCID 0000-0002-9933-5147
Ivan ČavargaInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-840 05 Bratislava, Slovakia.
Gabriela ZelenkováDepartment of Chemistry, Faculty of Science, University of Ostrava, 30, Dubna 22, CZ-701 03 Ostrava, Czech Republic.ORCID 0000-0002-7664-8802
Erik SedlákCenter for Interdisciplinary Biosciences, Technology and Innovation Park, Pavol Jozef Šafárik University in Košice, Jesenná 5, SK-041 54 Košice, Slovakia.ORCID 0000-0003-1290-5774
Miroslav AlmášiDepartment of Inorganic Chemistry, Faculty of Science, Pavol Jozef Šafárik University in Košice, Moyzesova 11, SK-041 54 Košice, Slovakia.ORCID 0000-0002-6044-6683
Veronika HuntošováInstitute of Animal Biochemistry and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, SK-840 05 Bratislava, Slovakia.ORCID 0000-0003-0042-2097
Funding
Slovak Research and Development Agency APVV-20-0129The EU NextGenerationEU through the Recovery and Resilience Plan for Slovakia BCOrgFluorIDA No. 09I03-03-V04-00007the Ministry of Education, Research, Development and Youth of the Slovak Republic VEGA 2/0081/25
6 · The paper itself
Abstract
The increasing prevalence of multidrug-resistant bacteria necessitates alternative therapeutic strategies that combine antimicrobial efficacy with immunomodulatory properties. Here, we report the immunostimulatory activity and antibacterial potential of the amino-functionalized metal-organic framework MIL-101(Al)-NH
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Immunostimulatory Effect of MIL-101(Al)-NH · full record | OpenQuestion